Nasdaq · CIK 0001540159
EDSA Edesa Biotech, Inc.
Insider trading from SEC Form 4. Last filing 7 d ago. Close $3.51 on Oct 9, 2026, +339% from the 52-week low and -81% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
EDSAOct 9, 2026 · close 3.51
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Edesa Biotech, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 23Weak | Michael J Brooks President buy | $3,140 2,000 shares | +1% | - | |
| 33Weak | Pardeep Nijhawan Chief Executive Officer buy | $6,599 1,000 shares | +0% | - | |
| 44Moderate | Pardeep Nijhawan Chief Executive Officer buy | $39k 10,000 shares | +3% | - | |
| 44Moderate | Pardeep Nijhawan Chief Executive Officer buy | $43k 10,000 shares | +3% | - | |
| 44Moderate | Pardeep Nijhawan Chief Executive Officer buy | $36k 10,000 shares | +3% | - | |
| 33Weak | Pardeep Nijhawan Chief Executive Officer buy | $6,280 3,000 shares | +0% | - | |
| 46Moderate | Pardeep Nijhawan Chief Executive Officer buy | $99k 50,571 shares | +8% | - |
Transactions
The last 44 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +6,893 | $0.00 | $0 | 905,993 | 7 d ago |
| Sep 1, 2026 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +5,714 | $0.00 | $0 | 899,100 | 42 d ago |
| May 27, 2026 | Michael J Brooks President | AGrant or award Common Shares | +64,609 | $0.00 | $0 | 291,479 | May 29, 2026 |
| Feb 26, 2026 | Michael J Brooks President | POpen-market purchase Common Shares | +2,000 | $1.57 | $3,140 | 226,870 | Mar 11, 2026 |
| Mar 10, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Shares | +1,000 | $6.60 | $6,599 | 628,813 | Mar 10, 2026 |
| Mar 5, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +10,000 | $3.90 | $39k | 402,702 | Mar 6, 2026 |
| Mar 4, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +10,000 | $4.26 | $43k | 392,702 | Mar 5, 2026 |
| Mar 3, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +10,000 | $3.63 | $36k | 382,702 | Mar 4, 2026 |
| Mar 2, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Shares | +2,000 | $2.00 | $4,000 | 627,813 | Mar 3, 2026 |
| Mar 2, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +1,000 | $2.28 | $2,280 | 372,702 | Mar 3, 2026 |
| Feb 26, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Shares | +20,571 | $1.58 | $32k | 615,797 | Mar 2, 2026 |
| Feb 19, 2026 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +82,236 | $0.00 | $0 | 595,226 | Mar 2, 2026 |
| Mar 2, 2026 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +10,016 | $0.00 | $0 | 625,813 | Mar 2, 2026 |
| Feb 27, 2026 | Pardeep Nijhawan Chief Executive Officer | POpen-market purchase Common Sharesindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +30,000 | $2.22 | $67k | 371,702 | Mar 2, 2026 |
| Feb 2, 2026 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +11,168 | $0.00 | $0 | 512,990 | Feb 2, 2026 |
| Jan 5, 2026 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +10,444 | $0.00 | $0 | 501,822 | Jan 5, 2026 |
| Dec 1, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +8,766 | $0.00 | $0 | 491,378 | Dec 2, 2025 |
| Nov 3, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +6,968 | $0.00 | $0 | 482,612 | Nov 6, 2025 |
| Oct 2, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +5,908 | $0.00 | $0 | 475,644 | Oct 3, 2025 |
| Sep 11, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +5,981 | $0.00 | $0 | 469,736 | Sep 12, 2025 |
| Aug 1, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +6,802 | $0.00 | $0 | 463,755 | Aug 4, 2025 |
| Jul 2, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +7,186 | $0.00 | $0 | 456,953 | Jul 2, 2025 |
| May 29, 2025 | Michael J Brooks President | AGrant or award Common Shares | +207,201 | $0.00 | $0 | 224,870 | Jun 2, 2025 |
| May 29, 2025 | Joan Chypyha director | AGrant or award Common Shares | +11,000 | $0.00 | $0 | 11,029 | Jun 2, 2025 |
| May 29, 2025 | Da David Liu director | AGrant or award Common Shares | +5,501 | $0.00 | $0 | 5,501 | Jun 2, 2025 |
| May 29, 2025 | Sean Arthur MacDonald director | AGrant or award Common Shares | +20,001 | $0.00 | $0 | 22,054 | Jun 2, 2025 |
| May 29, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +263,200 | $0.00 | $0 | 442,123 | Jun 2, 2025 |
| May 29, 2025 | Carlo Sistilli director | AGrant or award Common Shares | +20,001 | $0.00 | $0 | 30,417 | Jun 2, 2025 |
| May 29, 2025 | Charles Olson V director | AGrant or award Common Shares | +11,000 | $0.00 | $0 | 11,000 | Jun 2, 2025 |
| May 29, 2025 | Patrick Marshall director | AGrant or award Common Shares | +11,000 | $0.00 | $0 | 52,666 | Jun 2, 2025 |
| May 29, 2025 | Peter J. Weiler Chief Financial Officer | AGrant or award Common Shares | +65,000 | $0.00 | $0 | 65,000 | Jun 2, 2025 |
| Jun 2, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +7,644 | $0.00 | $0 | 449,767 | Jun 2, 2025 |
| May 2, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +6,392 | $0.00 | $0 | 178,923 | May 6, 2025 |
| Apr 1, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +5,784 | $0.00 | $0 | 172,531 | Apr 3, 2025 |
| Mar 3, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +6,339 | $0.00 | $0 | 166,747 | Mar 3, 2025 |
| Feb 12, 2025 | Patrick Marshall director | AGrant or award Common Shares | +41,666 | $1.92 | $80k | 41,666 | Feb 14, 2025 |
| Feb 12, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Series B-1 Convertible Preferred Sharesderivative | +100 | - | - | 100 | Feb 14, 2025 |
| Feb 12, 2025 | Carlo Sistilli director | AGrant or award Common Shares | +10,416 | $1.92 | $20k | 10,416 | Feb 14, 2025 |
| Feb 3, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +8,264 | $0.00 | $0 | 160,408 | Feb 4, 2025 |
| Jan 6, 2025 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +8,476 | $0.00 | $0 | 152,144 | Jan 6, 2025 |
| Dec 2, 2024 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +6,420 | $0.00 | $0 | 143,668 | Dec 3, 2024 |
| Nov 12, 2024 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Common Shares | +4,630 | $0.00 | $0 | 137,248 | Nov 12, 2024 |
| Oct 30, 2024 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Series A-1 Convertible Preferred Sharesderivativeindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +150 | - | - | 150 | Nov 1, 2024 |
| Oct 30, 2024 | Pardeep Nijhawan Chief Executive Officer | AGrant or award Warrants (right to buy)derivativeindirect: Held by Pardeep Nijhawan Medicine Professional Corporation | +326,560 | - | - | 326,560 | Nov 1, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Michael J BrooksPresident
- Joan Chypyhadirector
- Da David Liudirector
- Sean Arthur MacDonalddirector
- Patrick Marshalldirector
- Pardeep NijhawanChief Executive Officer
- Charles Olson Vdirector
- Carlo Sistillidirector
- Peter J. WeilerChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.